O'Shaughnessy Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,532
Closed -$134K 2666
2021
Q3
$134K Sell
1,532
-24
-2% -$2.17K ﹤0.01% 1239
2021
Q2
$139K Buy
1,556
+152
+11% +$12.8K ﹤0.01% 1191
2021
Q1
$106K Sell
1,404
-33
-2% -$2.49K ﹤0.01% 1176
2020
Q4
$98K Buy
1,437
+471
+49% +$29.4K ﹤0.01% 1074
2020
Q3
$51K Sell
966
-96
-9% -$5.72K ﹤0.01% 1077
2020
Q2
$62K Sell
1,062
-65
-6% -$3.49K ﹤0.01% 963
2020
Q1
$45K Buy
+1,127
New +$65.9K ﹤0.01% 803
2017
Q2
Sell
-916
Closed -$42K 983
2017
Q1
$42K Sell
916
-30
-3% -$1.49K ﹤0.01% 706
2016
Q4
$50K Sell
946
-57
-6% -$2.76K ﹤0.01% 712
2016
Q3
$45K Buy
1,003
+196
+24% +$8.5K ﹤0.01% 698
2016
Q2
$31K Buy
807
+192
+31% +$8.44K ﹤0.01% 727
2016
Q1
$25K Buy
+615
New +$25.3K ﹤0.01% 650

Other funds holding SYNH

O'Shaughnessy Asset Management's SYNH Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 1,532 shares — an estimated $134K sold.

O'Shaughnessy Asset Management first reported a position in SYNH in Q1 2016 and held it in 12 quarters. The position peaked at $139K in Q2 2021. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,532 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $134K.
  • O'Shaughnessy Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 12 quarters.
  • O'Shaughnessy Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $139K in Q2 2021.
  • 378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.